APA (7th ed.) Citation

Sirilertmekasakul, C., Panto, A., Lekhalawan, P., Panyarachun, P., Jindasakchai, P., & Rattanawong, W. (2024). The transition of medication overuse status by acute medication categories in episodic or chronic migraine patients to non-overuse status after receiving anti-CGRP monoclonal antibodies: A systematic review and meta-analysis of phase 3 randomized control trial. Neurological Sciences, 45(9), 4451. https://doi.org/10.1007/s10072-024-07496-7

Chicago Style (17th ed.) Citation

Sirilertmekasakul, Chananchida, Akkanat Panto, Pattanan Lekhalawan, Pariyada Panyarachun, Porpim Jindasakchai, and Wanakorn Rattanawong. "The Transition of Medication Overuse Status by Acute Medication Categories in Episodic or Chronic Migraine Patients to Non-overuse Status After Receiving Anti-CGRP Monoclonal Antibodies: A Systematic Review and Meta-analysis of Phase 3 Randomized Control Trial." Neurological Sciences 45, no. 9 (2024): 4451. https://doi.org/10.1007/s10072-024-07496-7.

MLA (9th ed.) Citation

Sirilertmekasakul, Chananchida, et al. "The Transition of Medication Overuse Status by Acute Medication Categories in Episodic or Chronic Migraine Patients to Non-overuse Status After Receiving Anti-CGRP Monoclonal Antibodies: A Systematic Review and Meta-analysis of Phase 3 Randomized Control Trial." Neurological Sciences, vol. 45, no. 9, 2024, p. 4451, https://doi.org/10.1007/s10072-024-07496-7.